New grants among 52 across the country
Three cancer studies led by Hamilton researchers are among 52 new research projects worth close to $22 million announced by the Canadian Cancer Society.
"We are very proud to support the innovative and ground-breaking research taking place in Hamilton and across the province," said Martin Kabat, CEO, Canadian Cancer Society, Ontario Division. "We are grateful to the generosity and efforts of our donors and volunteers who make this research possible."
The new grants were announced at McMaster University on April 27.
"At McMaster we see our role as taking part in a relay for life," said Fiona McNeill, associate vice-president, research and international affairs of McMaster University. "We take the baton of generous support from the Canadian Cancer Society, its donors and volunteers; and our scientists develop innovative advances towards cancer cures and better care that that can be passed on to patients and their families. This is very much appreciated."
McMaster researchers receiving new funding from the Canadian Cancer Society are:
Dr. Mick Bhatia $423,000
Mick Bhatia's lab continues its groundbreaking research turning adult skin into human stem cells to generate different types of blood cells. This study aims to identify the molecules required for "reprogramming" these cells, focusing on the Gli3 gene that works through the "Sonic Hedgehog Signaling Pathway". The goal is to create an unlimited source of blood for cancer patients requiring bone marrow transplants to fight the side effects of radiation and chemotherapy. Bhatia is a professor of biochemistry and biomedical sciences at McMaster and director of McMaster's Stem Cell and Cancer Research Institute.
Dr. Hsien Seow $671,615
Research by Hsien Seow has shown that end-of-life cancer patients in Ontario who received more homecare nursing hours were less likely to require hospital visits. This project will extend this research to three more provinces, investigate the effect of more homecare nursing hours on total healthcare costs, and determine whether patients use care differently depending on their province. Seow is an associate professor of oncology at McMaster and he holds the Cancer Care Ontario Research Chair in Health Services Research.
Dr. John Valliant $412,392
John Valliant is studying a way to develop a more precise, non-invasive method to detect breast cancer. With this funding, he will create an imaging probe to help identify insulin receptors that are abundant on the surface of breast cancer cells, with the goal of using this early change in cancer cells for screening and to predict the best treatment options. Valliant is an associate professor of chemistry at McMaster and CEO and scientific director of the Centre for Probe Development and Commercialization.
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients